Notice is hereby given that the following correction has been made to the proposed rule in Vol. 38 No. 8, February 24, 2012 issue of the Florida Administrative Weekly.

SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS:

A SERC has been prepared by the Agency. Based on information from the SERC, the Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. Also, based on this information at the time of the analysis and pursuant to Section 120.541, F.S., the rule will not require legislative ratification.

Any person who wishes to provide information regarding the statement of estimated regulatory costs or to provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

To summarize the SERC analysis, home and community based services waiver programs that offer disposable incontinence medical supplies will be impacted by this rule. The rule will impose no direct cost to state and local governments nor will it have any impact to state or local revenues. The Agency does not anticipate any impact on small counties or small cities. There will be no transactional costs for providers, as the billing codes being used are nationally recognized standard codes. Training for waiver support coordinators may be required to use the new billing codes and fees. At the time the SERC was completed, there were 653 disposable incontinence medical supply providers providing services to the waivers. The Agency did not receive any lower cost alternatives.